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Purpose: This study determined the plasma levels of nitric oxide 
(effector molecule in intracellular killing by phagocytes), regulators 
(C3 inactivator and C1 inhibitor) and factors (C4 and C3c) of 
Complement system and immunoglobulin classes (IgG, IgA and IgM) 
in HIV patients compared with HIV un-infected controls. The aim is 
to provide additional explanation for long persistence of human 
immunodeficiency virus (HIV) in HIV patients.  
Methods: The plasma levels of Complement regulators (C3 activator 
and C1 inhibitor), Complement factors (C3c and C4), 
immunoglobulin classes (IgG, A and M) were estimated using 
immunoplates in controls, HIV patients with <200 CD4+ T 
lymphocytes per microliter of blood and HIV patients with 200–499 
CD4+ T lymphocytes per microliter blood. Also the level of plasma 
NO was determined using Griess reagent.  
Results: The levels of C1 inh, C3 act, C3c, NO, IgG, IgA and IgM 
were significantly higher in all HIV patients compared to controls. 
The mean values of C1 inh and C4 were significantly higher in HIV 
patients with a CD4+ T lymphocytes <200 cells/ µl blood compared 
with HIV CD4+ T lymphocytes 200–499 cells/ µl blood. 
Conclusion: It may be concluded that plasma levels of C1 inh and C4 
might be used to distinguish HIV severity. 
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HIV patients showed abnormal patterns of serum 
protein electrophoresis [1], polyclonal hyper-
gammaglobulinemia, hyperproteinemia, and 
plasma cell dyscrasias [2, 3]. This may suggest 
that autoimmune responses or plasma cell 
neoplasia is associated with HIV infection.  Few 
autoantibodies (anti-Protein S autoantibodies, anti 
cardiolipin autoantibodies and anti-C1q 
autoantibodies) have been reported in HIV 
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patients [4, 5], thus increased concentrations of 
immunoglobulin classes obviously reflect 
abnormal underlying humoral immunological 
process of HIV. Therefore, it is possible that there 
are many other yet unrecognised autoantibodies 
in HIV patients. One of the aims of this study was 
to confirm polyclonal hypergammaglobulinemia 
and possible autoimmune disorder in HIV 
patients with low CD4 counts.  
 
Patients infected with HIV have high levels of 
circulating immune complexes [2, 6, 7], which 
are potent activators of the complement system. 
Reports on the levels and activities of 
Complement system in HIV patients are 
inconsistent. Complement activation in HIV 
patients was reported to be via classical pathway 
[6, 7, 10] but one study reported [8] alternate 
pathway of complement activation in HIV 
subjects. Despite these activations of 
Complement System in HIV patients, HIV 
survives in the patients. The virolysis of HIV was 
reported [11] to be prevented by complement 
regulatory molecules, which either are included 
in the virus membrane upon budding from 
infected cells (e.g. DAF/CD55) or are secondarily 
attached to HIV envelope glycoproteins (Factor 
H) [12].  
 
Another possible mechanism by which HIV 
escape complement lysis was reported to be 
mutated HIV envelope proteins [10, 13]. Thus 
complement-activating anti-HIV antibodies 
present in the plasma may be unable to bind and 
lyse HIV [10, 13]. The present study therefore 
provides additional information to intrinsic 
resistance of HIV to complement-mediated 
virolysis in HIV patients. This was done by 
measuring C1 inhibitor and C3 activators as 
regulators of classical and alternate pathways of 
complement activation respectively while the 
levels of C4 and C3c were measured as factors of 
classical and alternate pathways of complement 
system respectively.  
 
Polymorphonuclear leucocytes produce reactive 
oxygen radical during intracellular killing of 
ingested particles. In HIV subjects, phagocytotic 
activity was reported to be reduced due to down 
regulation of IL-12, impaired phagosome-
lysosome fusion by gp 120 [14], inhibition of 
chemotaxis by Nef protein [15]. This impairment 
allows for establishment and reactivation of 
opportunistic infections [16]. However, it was 
reported that in the early stages of HIV infection, 
phagocytosis by monocytic/polymorphonucleated 
cells and release of reactive oxygen products 
were increased [17]. The present study 





A total of 36 consecutive HIV patients aged 22–
69 years were recruited for this case control study 
in Haematology Department, University College 
Hospital, Ibadan, Nigeria. Twenty-nine age-/sex-
matched healthy HIV-negative health workers 
(23-65years) were recruited as controls. Informed 
consent was obtained from each subject before 
collection of blood samples. A sample of 5 ml of 
venous blood was collected from the antecubital 
vein without venous stasis from each patient into 
bottle with anticoagulants. The blood samples 
were centrifuged in MSE centrifuge for 10 min at 
3,500 rpm. The plasma was immediately placed 
in a freezer until analysis. The main outcome 
measures were IgG, IgA, IgM, C3c,  
 
The plasma levels of immunoglobulin classes and 
Complement factors/regulators were measured 
using immunoplates. The method is based on the 
principle of single radial immunodiffusion as 
previously described [1]. Radial immunodiffusion
 
involves radial diffusion of a specific antigen 
through an agarose gel containing the
 
appropriate 
mono-specific antibody. During radial diffusion,
 
stable antigen-antibody complexes are formed at 
equilibrium which appears as a visible
 
ring. The 
diameter of the ring is a proportional to the 
concentration of the antigen. The level of NO was 
determined using Griess reagents and method 
[18]. Structured questionnaire was used to obtain 
socio-demographic data while Body Mass Index 
(BMI) was calculated using the values of height 
and weight. 
 
Those with presence of confounding illnesses 
were excluded. Also excluded are cigarette 
smokers or those on locally brewed drinks were 
excluded. Others excluded were those with high 
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abnormal liver functions, pathogenic infections 
and abnormal renal functions as presented by 
blood, urine and stool tests. Other exclusion 
criteria were subjects with rheumatic fever, 
rheumatoid arthritis, subjects who received oral 
contraceptives, nonsteroidal anti-inflammatory 
drugs, corticosteroids, anticon-vulsants and 
antidepressants. Those that declined their 
consents were also excluded. These exclusion 
criteria lead to the numbers of alcohol consumers 
(n = 36) and controls (n = 29) in the study. 
 
The laboratory investigations that were carried 
out and the reasons are provided in Table 1.  
 





To exclude anaemia, 
leucopenia, leucocytosis, 
eosinophilia or any other 




To exclude increased T3 and 
T4 serum levels or patients 
with low serum T3 and T4 
levels 
Renal function tests 
(blood urea and 
serum creatinine) 
To exclude renal impairment 
Liver function tests To exclude liver affection, 
especially those with high 
liver enzymes or those with 
diminished albumin levels or 
high globulin levels 
Urine and stool 
analysis 
To exclude urinary tract 





The biochemical indices were determined as 
means with their respective standard deviations. 
The significances of the differences between 
mean values were determined using Students (t) 
test. Chi-square was used to test for significance 
between socio-demograhic and clinical variables 
of patients and control subjects. At 95% 
confidence interval p values below 0.05 were 




The levels of C1 inh, C3 act, C3c, NO, IgG, IgA 
and IgM were significantly higher in all HIV 
patients or HIV patients with <200 CD4+ T 
lymphocytes per microliter blood or HIV patients 
having between 200–499 CD4+ lymphocytes per 
microliter blood compared with controls. C4 was 
significantly reduced in HIV subjects having 
200–499 CD4 cells/µl blood compared with 
controls or HIV subjects having <200 CD4 
cells/µl blood (Table 2). However, C4 was not 
significantly different in all HIV patients or in 
HIV subjects having <200 CD4 cells/µl blood 
compared with the controls. The mean values of 
C1 inh was significantly higher in HIV patients 
with a CD4 <200 CD4 cells/µl blood compared 
with 200–499 CD4 cells/µl blood while the levels 
of C3act, NO, C3c, IgA, IgG and IgM were not 
significantly different in HIV patients with a CD4 
count of <200 CD4 cells/µl blood compared with 
200–499 CD4 cells/µl blood (Table 2).  
 
Most of the HIV patients were unemployed and 




Immunoglobulin classes were significantly raised 
in HIV patients compared with controls but there 
were no significant difference in the levels of Ig 
classes when patients with CD4+ T cell count 
below 200 were compared with patients having 
CD4+ T cell 200-400 per microliter of blood. The 
implication is that plasma concentrations of Ig 
classes might not be useful in differentiating 
severity of HIV. The present observation of 
raised Ig classes support non-specific polyclonal 
B cell activation in HIV subjects as previously 
reported [2,3]. Polyclonally raised immuno-
globulins are common with many infective and 
inflammatory conditions [2,3]. HIV infection is 
inflammatory in nature as reported by high 
concentrations of certain acute phase proteins. 
 
Other possibilities for raised levels of Ig classes 
in HIV patients might be abnormalities of 
lymphokines or other signals from co-infections 
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Table 2: The plasma levels of NO, Immunoglobulin classes, Complement Regulators and Complement Factors in 
HIV patients and control 
 
 Control (n = 29) HIV (n = 36) <200 CD4cells/µl 
blood (n= 26) 
200–499 CD4cells/ 





C4 (g/L)  
C3c (g/L) 
C3 activator (g/L) 
C1 inhibitor (g/L) 
4.02 ± 1.69 
547.1 ± 188 
107.3 ± 26 
45.4 ± 17 
0.15 ± 0.07 
0.63 ± 0.16 
0.34 ± 0.11 
0.48 ± 0.2 
5.34 ± 1.96* 
871 ± 176.1* 
153 ± 41* 
99.8 ± 33.7* 
0.15 ± 0.05 
0.77 ± 0.27* 
0.51 ± 0.31* 
0.77 ± 0.37* 
6.45 ± 2.64* 
880 ± 164* 
155 ± 31* 
92 ± 30* 
0.15 ± 0.05 
0.84 ± 0.28* 
0.61 ± 0.45* 
0.97 ± 0.43* 
5.98 ± 2.18* 
859 ± 187* 
150 ± 51* 
111.3 ± 35.3* 
0.12 ± 0.04*◙ 
0.84 ± 0.34* 
0.54 ± 0.21* 
0.56 ± 0.30*◙ 
*Significantly different from controls at p <0.05 (2-tailed); ◙Significantly different from HIV <200CD4cells/µl 
blood at p <0.05 (2-tailed) 
 
Table 3: Socio-demographic characteristics and 




























*Unemployed   
 
Educational Status: 
Below Sec School    
Above Sec School  
 
Sexual Orientation: 
Heterosexual                
Homosexual  
 
Mode of Transmission: 
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such as bacterial lipopolysaccharide and similar 
bacterial products. Studies of unregulated or 
abnormal regulation of B cell functions and / or T 
cell functions usually result in autoantibody 
formation [3-5]. This therefore supports the 
possibility of autoimmune responses or auto-
antibody formation in HIV patients, which 
requires further investigation.  There is evidence 
of a slightly increased risk of multiple myeloma 
occurring in HIV patients [3], and there have 
been a number of case reports of unequivocal 
multiple myeloma in HIV patients. Amara et al 
[19] reported that 28% of their HIV patients with 
monoclonal gammopathy developed malignancy 
(usually a B-cell/plasma cell malignancy) after a 
mean follow-up of 21 months. 
 
Complement system functions in interactive 
sequence and it serves a very important role in 
host defense but can be detrimental when not 
regulated [7]. One of the regulators of classical 
pathway is C1 inhibitor. C1 inhibitor (C1-INH) 
inhibits C1r and C1s by binding covalently to 
them, causing disassembly of C1 macromolecular 
complex. The inhibitor is synthesized in the liver 
and blood monocyte. The alternative pathway is 
regulated by C3 activator (among others), which 
cleaves C3 into anaphylatoxin (C3a) and C3b. 
 
There were significantly raised levels of C3c, C3 
activator and C1 inhibitor in HIV patients 
compared with controls. This observation is 
comparable to previous studies [6, 9] that 
reported significantly higher levels of other 
complement factors such as C4d, Ba and C3d in 
HIV patients. The implication of the present 
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results is that activation of classical pathway of 
complement system in HIV patients was reduced 
but alternative complement pathway was 
increased as a compensatory mechanism. Other 
researchers [6,9,10] have reported that activation 
of complement system in HIV patients was 
mainly via classical pathway. The present study 
is in line with Eitan et al [8] that reported 
alternative complement activation pathway in 
HIV patients. 
 
NO is produced during intracellular killing by 
phagocytes and inflammation [16]. It might be 
speculated that elevated NO in HIV patients was 
in response to inflammation. NO was reported to 
induce tissue damage especially after conversion 
into peroxynitrite radical (ONOO·) [20], thus 
elevated NO in HIV patients might have 





C1 inh and C4 appear to be good candidates that 
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